Dissociation between cardiometabolic markers and symptom severity in restless legs syndrome: A retrospective case-control study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Restless legs syndrome (RLS) has been associated with adverse cardiometabolic features, but whether these abnormalities independently characterize RLS or relate to symptom severity remains uncertain. This study evaluated lipid-derived cardiometabolic markers, including the atherogenic index of plasma (AIP), and the atherosclerotic cardiovascular disease (ASCVD) score in RLS and examined their relationships with symptom severity. This retrospective case-control study included 110 patients with RLS and 100 non-RLS controls. Analyses included unadjusted comparisons, false discovery-rate-corrected correlations with the International Restless Legs Syndrome Rating Scale (IRLS), multivariable regression, body mass index (BMI)-adjusted robust models, RLS subtype analyses, and an age-restricted ASCVD sensitivity analysis. An additional exploratory IRLS model included recorded treatment category and RLS subtype. In unadjusted comparisons, patients with RLS had higher BMI, triglycerides, AIP, triglyceride/high-density lipoprotein ratio, Castelli indices, C-reactive protein, systolic blood pressure, and exploratory full-sample ASCVD scores and lower ferritin. However, differences in AIP and the other lipid-derived indices were no longer significant after BMI adjustment (all P ≥ .102). No statistically significant correlation between a lipid-derived index and IRLS was detected. Disease duration showed a strong correlation with severity (rho = 0.674, P < .001). The ferritin association was attenuated after subtype adjustment (P = .091) but was significant in the exploratory treatment category and subtype-adjusted model (P = .001); AIP remained nonsignificant in that model (B=-2.320; 95% confidence interval, -4.958-0.318; P = .084). Age-restricted ASCVD analyses detected no statistically significant group difference or association with IRLS. Crude lipid-index differences were attenuated after BMI adjustment, and statistically significant lipid-severity associations were not detected. Disease duration remained associated with symptom burden, whereas ferritin findings varied across models. Treatment exposure, subtype heterogeneity, and imprecision limit inference; nonsignificant results do not establish absence of an association. These findings do not establish lipid-derived indices or ASCVD as stand-alone diagnostic or severity markers for RLS.
Source: Medicine
Authors: Elif Simin Issı, Elif Topay
Institution: Afyonkarahisar Sağlık Bilimleri Üniversitesi
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,950
OpenAlex ID: W7237202893
